retatrutide phase 2 trial obesity triple agonist 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Triple hormone receptor agonist retatrutide

What's the difference between compounded and brand-name GLP-1 medications

Studies suggest that, rather than acting primarily through GLP-1-producing neurons in the hindbrain or GLP-1 receptors in the vagus nerve, these drugs mediate weight loss via the arcuate nucleus (ARC) of the hypothalamus [55,56]

9,11,20 Some studies have suggested that GLP-1RA medications may reduce the incidence of gastrointestinal cancers, 4 such as colorectal cancer

Potential Links to Hair Follicle Biology Research has also examined the peptide in relation to dermal papilla cells (DPCs), specialized fibroblasts implicated in hair follicle development